This report examines examples of new and emerging governance models that aim to support the responsible development of diagnostics and treatments based on the latest advances in biomedicine. In particular, it presents programmes and initiatives that aim to manage uncertainty in the development and approval of new medical products and thereby to improve the understanding of the risk/benefit balance. It also identifies some of the main challenges for policy makers, regulators and other communities involved in the translation of biomedical innovation and health technologies from the laboratory bench to point of care.
Toward New Models for Innovative Governance of Biomedicine and Health Technologies
Policy paper
OECD Science, Technology and Industry Policy Papers
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
24 April 2024
-
20 November 2023
Related publications
-
24 April 2024